GLP-1 Agonist Manufacturers: Leading Companies and the Future of GLP-1 Therapies
Introduction
GLP-1 agonists have become one of the most important areas of modern metabolic medicine. Originally developed primarily for the management of type 2 diabetes, these therapies have expanded into obesity and weight-management applications, creating significant demand for innovative medicines, manufacturing capacity, and next-generation treatment options.
The market includes established...
AI Biotechnology Companies: Leading Companies Transforming Drug Discovery and Life Sciences
Introduction
Artificial intelligence is becoming an increasingly important technology across the biotechnology and life sciences industries. From drug discovery and molecular design to genomics, biomarker identification, and precision medicine, AI biotechnology companies are developing technologies that can help researchers analyze complex biological information and make faster, data-driven decisions.
The...
Negative Pressure Wound Therapy Equipment: Overview, Applications, and Market Trends
Negative Pressure Wound Therapy (NPWT) equipment is an advanced wound-care technology used to support the management and healing of acute, chronic, surgical, traumatic, and other complex wounds. The therapy uses controlled negative pressure to remove wound exudate, help manage edema, support tissue formation, and create an appropriate wound-healing environment.
According to MarketsandMarkets,...
Biosimilars Market: Affordable Biologic Therapies Accelerate Growth Through 2035
The global biosimilars market is transforming the biopharmaceutical landscape by expanding access to high-quality biologic therapies at more affordable prices. The biosimilars market size is projected to grow from USD 35.04 billion in 2025 to USD 72.29 billion by 2035, registering a CAGR of 7.5% during the forecast period. The market was valued at USD 32.75 billion in 2024.
The increasing prevalence...
Lab on a chip technology Market to Reach USD 21.36 Billion by 2030
The global lab on a chip technology Market is projected to grow from USD 14.01 billion in 2025 to USD 21.36 billion by 2030, registering a CAGR of 8.8% during the forecast period. Market growth is being driven by increasing demand for high-throughput and cost-effective diagnostic technologies, expanding genomics and proteomics research, growing adoption of personalized medicine,...
Immunoassay Testing Market to Reach USD 47.7 Billion by 2030
The global Immunoassay testing Market is projected to grow from USD 35.5 billion in 2025 to USD 47.7 billion by 2030, registering a CAGR of 6.1% during the forecast period. Market expansion is being driven by the growing burden of chronic and infectious diseases, an aging global population, increasing demand for early disease detection, and continued adoption of automated...
Residual DNA Testing Market to Reach USD 0.37 Billion by 2030
The global Residual DNA Testing Market is projected to grow from USD 0.28 billion in 2025 to USD 0.37 billion by 2030, registering a CAGR of 6.0% during the forecast period. The market’s growth is primarily driven by increasing regulatory approvals for biologics and biosimilars, stringent product safety and quality requirements, and rising investments in advanced therapeutic...
Epigenetics Market: Growth, Trends, Drivers, and Emerging Opportunities Through 2031
The global epigenetics market is entering a period of strong expansion as researchers, pharmaceutical companies, biotechnology firms, and clinical laboratories increasingly adopt technologies that can reveal how gene activity is regulated without changing the underlying DNA sequence. The market is projected to grow from USD 2.22 billion in 2026 to USD 3.92 billion by 2031, registering a CAGR of 12.0%...
Pharmaceutical Contract Manufacturing Market to Reach USD 311.95 Billion by 2030
The global Pharmaceutical Contract Manufacturing Market is projected to grow from USD 209.90 billion in 2025 to USD 311.95 billion by 2030, registering a CAGR of 8.2% during the forecast period. Growth is being driven by the increasing outsourcing of pharmaceutical production, capacity constraints in high-demand therapeutic categories such as GLP-1 drugs, continued development...
Drug Discovery Services Market to Reach USD 27.23 Billion by 2030
Market Overview
The global Drug Discovery Services Market is expanding rapidly as pharmaceutical and biotechnology companies increasingly outsource research activities to specialized contract research organizations (CROs). According to MarketsandMarkets, the market is projected to grow from USD 16.36 billion in 2025 to USD 27.23 billion by 2030, registering a CAGR of 10.7% during...